サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1789190

精密腫瘍学技術市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、コンポーネント、展開、ステージ

Precision Oncology Technologies Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Component, Deployment, Stage

出版日
ページ情報
英文 305 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.45円
精密腫瘍学技術市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、コンポーネント、展開、ステージ
出版日: 2025年08月12日
発行: Global Insight Services
ページ情報: 英文 305 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

精密腫瘍学技術市場は、2024年の1,140億米ドルから2034年には3,021億米ドルに拡大し、CAGR約9%で成長すると予測されています。精密腫瘍学技術市場には、ゲノム、プロテオミクス、バイオインフォマティクスを統合し、個々のがんプロファイルに合わせた先進的診断・治療ツールが含まれます。これらの技術によって個別化された治療計画が可能になり、固有の遺伝子変異を標的とすることで患者の転帰が改善されます。分子診断の急速な進歩とがん研究への投資の増加が市場の成長を後押ししており、バイオマーカー探索と標的治療における機会が強調されています。

精密腫瘍学技術市場は、世界の関税、地政学的リスク、進化するサプライチェーン力学の影響を大きく受けています。日本と韓国は、貿易摩擦に対応して国内能力を強化し、外国技術への依存を減らすことを目指しています。中国は、地政学的要因と強力なヘルスケアアジェンダの両方によって、国産の精密腫瘍学ソリューションへの投資を加速させています。半導体供給の要である台湾は、地政学的な脆弱性に直面しているが、依然として不可欠です。精密腫瘍学の世界市場は、技術の進歩とがん罹患率の上昇に牽引され、力強い成長を遂げています。2035年までには、地域間の連携と技術革新の拡大により、市場は進化すると予想されます。中東の紛争は、エネルギー価格の変動を通じて間接的に市場に影響を与え、運用コストやサプライチェーンの安定性に影響を与える可能性があります。

市場セグメンテーション
タイプ 診断、治療、予後診断、予測バイオマーカー
製品 遺伝子検査、コンパニオン診断、リキッドバイオプシー、次世代シーケンス、免疫組織化学、蛍光in situハイブリダイゼーション
サービス コンサルテーション、ゲノムプロファイリング、データ解釈、臨床検査サービス
技術 遺伝子シーケンス、ポリメラーゼ連鎖反応、マイクロアレイ、バイオインフォマティクス、ナノテクノロジー
用途 乳がん、肺がん、大腸がん、前立腺がん、黒色腫、白血病
エンドユーザー 病院、診断ラボ、研究機関、製薬会社、バイオテクノロジー企業
コンポーネント ソフトウェア、ハードウェア、試薬、キット、消耗品
展開 オンプレミス、クラウドベース、ハイブリッド
ステージ 早期がん、進行がん、再発がん

精密腫瘍学技術市場は、個別化がん治療とゲノムプロファイリングの進歩に後押しされて急速に発展しています。診断セグメントでは、遺伝子検査が、特定の変異を同定し標的治療を導く能力によって、トップクラスのサブセグメントとして浮上しています。リキッドバイオプシー技術は、疾患の進行や治療効果をモニタリングするための非侵襲的な選択肢を提供するもので、これに続きます。治療セグメントでは、分子レベルの知見を活用してがん細胞を正確に攻撃する薬剤を開発する標的治療がリードしています。免疫療法（特にチェックポイント阻害剤）は、がん治療への変革的影響を反映し、2番目に業績の高いサブセグメントとなっています。

精密腫瘍学における人工知能の統合は勢いを増しており、診断精度と治療の個別化を強化しています。データ分析と予測モデリングのためのAI主導型プラットフォームは、がん専門医にとって不可欠なツールになりつつあります。バイオテクノロジー企業と研究機関の共同開発はイノベーションを促進し、新規治療や診断アプローチの開発を加速させています。患者の転帰の改善とヘルスケアコストの削減が期待されることから、精密腫瘍学技術への投資は今後も続くと予想されます。

精密腫瘍学技術市場は、市場シェア、価格戦略、新製品導入のダイナミック相互作用によって特徴付けられます。主要企業は、診断精度と治療効果を高める革新的なソリューションに注力しています。価格競争は、技術の進歩や個別化がん治療に対する需要の影響を受けながら続いています。アンメット・メディカル・ニーズへの対応と患者の予後改善への取り組みを反映して、新製品の発売は頻繁に行われています。市場は、がん罹患率の増加や精密医療の重視の高まりに後押しされています。

競合に関しては、主要参入企業は競争優位性を維持するため、絶えず相互ベンチマーキングを行っています。規制当局の影響も大きく、厳格なガイドラインが製品開発と承認プロセスを形成しています。市場情勢は戦略的提携や共同研究によってさらに影響を受け、研究能力や市場展開が強化されています。北米のと欧州は規制基準の最前線にあるが、アジア太平洋の新興市場は精密腫瘍学技術を急速に導入しています。人工知能とゲノミクスの統合は市場に革命をもたらし、大幅な成長が期待できます。

この地域では規制の枠組みが重視されていることも、イノベーションを助長する環境を育んでいます。アジア太平洋では、がん罹患率の上昇と医療費の増加によって市場が急成長しています。中国やインドのような国々は、技術の進歩と精密腫瘍学に対する意識の高まりによって、重要な参入企業として台頭してきています。ラテンアメリカと中東・アフリカは、精密腫瘍学技術の可能性を徐々に認識しつつあります。これらの地域では、投資や共同研究が増加しており、将来の成長と革新への道が開かれつつあります。

もう一つの重要な動きとして、Thermo Fisher Scientificはゲノム診断の主要企業の買収を完了し、精密腫瘍学の能力を増強しました。この買収により、サーモフィッシャーのポートフォリオが強化され、がん患者に対するより包括的な診断ソリューションが可能になると期待されています。

一方、ガーダントヘルス社は、従来型生検に代わる、より低侵襲で腫瘍遺伝子をリアルタイムで把握できる革新的なリキッドバイオプシー検査を発売しました。この製品の発売は、治療決定の精度を高めることにより、がん診断に革命をもたらすと期待されています。

規制面では、米国FDAは革新的な治療法をより迅速に市場に投入することを目的として、高精度がん治療の承認プロセスを迅速化する新しいガイドラインを導入しました。このような規制の変化は、このセグメントのさらなる進歩を刺激しそうです。

財政面では、精密腫瘍学市場は多額の投資を集めており、ベンチャーキャピタル企業はAIを活用した腫瘍学ソリューションに特化した新興企業に多額の資金を投入しています。このような資本の流入は、市場の可能性と、がん医療を変革するために技術を活用することへの関心の高まりを裏付けています。

主要動向と促進要因

精密腫瘍学技術市場は、いくつかの主要動向と促進要因に後押しされ、力強い拡大を経験しています。重要な動向は、ゲノムシーケンス技術の進歩であり、個別化治療計画に不可欠ながん変異のより正確な同定を可能にしています。この技術的進歩により、精密腫瘍学はより身近で費用対効果の高いものとなっています。

もう一つの動向は、製薬会社と技術企業との協力関係の拡大です。こうした提携により、革新的な診断ツールや治療法の開発と商業化が加速しています。さらに、腫瘍学における人工知能と機械学習の統合は、予測分析を強化し、患者の転帰と治療効率の改善につながります。

この市場促進要因には、世界のがんの有病率の増加が含まれ、より的を絞った効果的な治療法の需要が促されています。政府やヘルスケア機関は、がん治療に革命をもたらす可能性を認識し、精密医療構想に多額の投資を行っています。患者中心の治療モデルの台頭も精密腫瘍学の採用を後押ししており、患者とヘルスケア提供者は生活の質と生存率を向上させるオーダーメイドの治療選択肢を求めています。こうした動向と促進要因によって、精密腫瘍学技術市場は大幅な成長を遂げ、利害関係者に有利な機会を提供する態勢が整っています。

抑制要因と課題

精密腫瘍学技術市場は、いくつかの重大な抑制要因と課題に直面しています。第一に、精密腫瘍学治療と技術のコストが高いため、特に低所得地域ではその利用が制限されます。この経済的障壁が普及を妨げ、患者の最先端治療へのアクセスを制限しています。第二に、がんゲノミクスの複雑さと多様性は、データの解釈と臨床的意思決定に課題をもたらします。この複雑さには高度に専門化された専門知識が要求されるが、それは必ずしも容易に入手できるものではないです。第三に、新技術に対する規制上のハードルと長い承認プロセスが、市場参入と技術革新を遅らせる可能性があります。このような規制上の課題は、技術進歩のペースを阻害しかねないです。第四に、精密腫瘍学のための標準化されたプロトコルがないため、治療結果に一貫性がないです。この標準化の欠如は、精密腫瘍学の日常臨床への統合を複雑にしています。最後に、精密腫瘍学には機密性の高い患者情報が不可欠であるため、強固なデータプライバシーとセキュリティ対策の必要性が極めて重要です。データ保護規制を確実に遵守することは、依然として困難な課題です。

目次

第1章 精密腫瘍学技術市場概要

  • 調査目的
  • 精密腫瘍学技術市場の定義と調査範囲
  • レポートの制限事項
  • 調査対象年と通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 精密腫瘍学技術市場展望

  • 精密腫瘍学技術市場のセグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 精密腫瘍学技術の市場戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • 使用事例分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析

第6章 精密腫瘍学技術の市場規模

  • 精密腫瘍学技術の市場規模：金額別
  • 精密腫瘍学技術の市場規模、数量別

第7章 精密腫瘍学技術市場：タイプ別

  • 市場概要
  • 診断
  • 治療
  • 予後予測
  • 予測バイオマーカー
  • その他

第8章 精密腫瘍学技術市場：製品別

  • 市場概要
  • 遺伝子検査
  • コンパニオン診断
  • リキッドバイオプシー
  • 次世代シーケンサー
  • 免疫組織化学
  • 蛍光in situハイブリダイゼーション
  • その他

第9章 精密腫瘍学技術市場：サービス別

  • 市場概要
  • コンサルテーション
  • ゲノムプロファイリング
  • データ解釈
  • 臨床検査サービス
  • その他

第10章 精密腫瘍学技術市場：技術別

  • 市場概要
  • 遺伝子シーケンス
  • ポリメラーゼ連鎖反応
  • マイクロアレイ
  • バイオインフォマティクス
  • ナノテクノロジー
  • その他

第11章 精密腫瘍学技術市場：用途別

  • 市場概要
  • 乳がん
  • 肺がん
  • 大腸がん
  • 前立腺がん
  • 黒色腫
  • 白血病
  • その他

第12章 精密腫瘍学技術市場：エンドユーザー別

  • 市場概要
  • 病院
  • 診断ラボ
  • 研究機関
  • 製薬会社
  • バイオテクノロジー企業
  • その他

第13章 精密腫瘍学技術市場：コンポーネント別

  • 市場概要
  • ソフトウェア
  • ハードウェア
  • 試薬
  • キット
  • 消耗品
  • その他

第14章 精密腫瘍学技術市場：展開別

  • 市場概要
  • オンプレミス
  • クラウドベース
  • ハイブリッド
  • その他

第15章 精密腫瘍学技術市場：ステージ別

  • 市場概要
  • 早期がん
  • 進行がん
  • 再発がん
  • その他

第16章 精密腫瘍学技術市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他の中東・アフリカ

第17章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第18章 企業プロファイル

  • AliveCor
  • Withings
  • Biobeat
  • Qardio
  • Empatica
  • iRhythm Technologies
  • Garmin
  • Omron Healthcare
  • Fitbit
  • Huami
  • Polar Electro
  • Bittium
  • Hexoskin
  • VivaLNK
  • MyZone
  • Sensoria
  • CardiacSense
  • Actxa
  • Amazfit
  • Wellue
目次
Product Code: GIS32792

Precision Oncology Technologies Market is anticipated to expand from $114.0 Billion in 2024 to $302.1 Billion by 2034, growing at a CAGR of approximately 9%. The Precision Oncology Technologies Market encompasses advanced diagnostic and therapeutic tools tailored to individual cancer profiles, integrating genomics, proteomics, and bioinformatics. These technologies enable personalized treatment plans, improving patient outcomes by targeting unique genetic mutations. Rapid advancements in molecular diagnostics and increased investment in cancer research are propelling market growth, highlighting opportunities in biomarker discovery and targeted therapies.

The Precision Oncology Technologies Market is significantly influenced by global tariffs, geopolitical risks, and evolving supply chain dynamics. Japan and South Korea are bolstering their domestic capabilities in response to trade tensions, aiming to reduce dependency on foreign technologies. China is accelerating its investment in homegrown precision oncology solutions, driven by both geopolitical factors and a robust healthcare agenda. Taiwan, pivotal in semiconductor supply, faces geopolitical vulnerabilities yet remains indispensable. The global market for precision oncology is witnessing robust growth, driven by technological advancements and rising cancer prevalence. By 2035, the market is expected to evolve with increased regional collaborations and innovation. Middle East conflicts may indirectly affect the market through energy price volatility, influencing operational costs and supply chain stability.

Market Segmentation
TypeDiagnostics, Therapeutics, Prognostics, Predictive Biomarkers
ProductGenetic Tests, Companion Diagnostics, Liquid Biopsy, Next-Generation Sequencing, Immunohistochemistry, Fluorescence In Situ Hybridization
ServicesConsultation, Genomic Profiling, Data Interpretation, Clinical Trial Services
TechnologyGene Sequencing, Polymerase Chain Reaction, Microarray, Bioinformatics, Nanotechnology
ApplicationBreast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia
End UserHospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Firms
ComponentSoftware, Hardware, Reagents, Kits, Consumables
DeploymentOn-Premises, Cloud-Based, Hybrid
StageEarly-Stage Cancer, Advanced-Stage Cancer, Recurrent Cancer

The Precision Oncology Technologies Market is evolving rapidly, propelled by advancements in personalized cancer treatment and genomic profiling. Within the diagnostics segment, genetic testing emerges as the top-performing sub-segment, driven by its ability to identify specific mutations and guide targeted therapies. Liquid biopsy technologies follow closely, offering non-invasive options for monitoring disease progression and treatment response. In the therapeutics segment, targeted therapy leads, leveraging molecular insights to develop drugs that precisely attack cancer cells. Immunotherapy, particularly checkpoint inhibitors, represents the second highest-performing sub-segment, reflecting its transformative impact on cancer care.

The integration of artificial intelligence in precision oncology is gaining momentum, enhancing diagnostic accuracy and treatment personalization. AI-driven platforms for data analysis and predictive modeling are becoming indispensable tools for oncologists. Collaboration between biotech firms and research institutions is fostering innovation, accelerating the development of novel therapeutics and diagnostic approaches. Investment in precision oncology technologies is expected to continue, driven by the promise of improved patient outcomes and reduced healthcare costs.

The Precision Oncology Technologies Market is characterized by a dynamic interplay of market share, pricing strategies, and new product introductions. Leading companies are focusing on innovative solutions that enhance diagnostic accuracy and treatment efficacy. Pricing remains competitive, influenced by technological advancements and the demand for personalized cancer therapies. New product launches are frequent, reflecting the sector's commitment to addressing unmet medical needs and improving patient outcomes. The market is buoyed by the increasing prevalence of cancer and the growing emphasis on precision medicine.

In terms of competition, key players are continuously benchmarking against each other to maintain a competitive edge. Regulatory influences are significant, with stringent guidelines shaping product development and approval processes. The market landscape is further influenced by strategic alliances and collaborations, enhancing research capabilities and market reach. North America and Europe are at the forefront of regulatory standards, while emerging markets in Asia-Pacific are rapidly adopting precision oncology technologies. The integration of artificial intelligence and genomics is poised to revolutionize the market, offering substantial growth prospects.

Geographical Overview:

The Precision Oncology Technologies Market is witnessing a dynamic expansion across various regions, each contributing uniquely to its growth. North America leads, driven by advanced healthcare infrastructure and substantial investments in precision medicine research. The presence of major biotech firms accelerates technological advancements, enhancing the region's market dominance. In Europe, robust government initiatives supporting personalized medicine and a strong focus on research and development are propelling market growth.

The region's emphasis on regulatory frameworks also fosters a conducive environment for innovation. In the Asia Pacific, the market is burgeoning, fueled by increasing cancer prevalence and rising healthcare expenditures. Countries like China and India are emerging as significant players, driven by technological advancements and growing awareness of precision oncology. Latin America and the Middle East & Africa are gradually recognizing the potential of precision oncology technologies. These regions are witnessing increased investments and collaborations, paving the way for future growth and innovation.

Recent Developments:

The Precision Oncology Technologies Market has experienced notable developments in recent months. Roche announced a strategic partnership with Illumina to enhance its precision oncology offerings, focusing on integrating genomic sequencing technologies to optimize cancer treatment strategies. This collaboration aims to accelerate the development of personalized cancer therapies.

In another significant move, Thermo Fisher Scientific completed the acquisition of a leading genomic diagnostics company, augmenting its capabilities in precision oncology. This acquisition is expected to bolster Thermo Fisher's portfolio, enabling more comprehensive diagnostic solutions for oncology patients.

Meanwhile, Guardant Health launched an innovative liquid biopsy test designed to provide real-time insights into tumor genetics, offering a less invasive alternative to traditional biopsies. This product launch is anticipated to revolutionize cancer diagnostics by enhancing the precision of treatment decisions.

On the regulatory front, the U.S. FDA has introduced new guidelines to expedite the approval process for precision oncology drugs, aiming to bring innovative treatments to market more swiftly. This regulatory shift is likely to stimulate further advancements in the sector.

Financially, the precision oncology market has attracted substantial investment, with venture capital firms injecting significant funds into startups specializing in AI-driven oncology solutions. This influx of capital underscores the market's potential and the growing interest in leveraging technology to transform cancer care.

Key Trends and Drivers:

The Precision Oncology Technologies Market is experiencing robust expansion, fueled by several key trends and drivers. A significant trend is the advancement of genomic sequencing technologies, enabling more precise identification of cancer mutations, which is crucial for personalized treatment plans. This technological progress is making precision oncology more accessible and cost-effective.

Another trend is the growing collaboration between pharmaceutical companies and technology firms. These partnerships are accelerating the development and commercialization of innovative diagnostic tools and treatments. Furthermore, the integration of artificial intelligence and machine learning in oncology is enhancing predictive analytics, leading to improved patient outcomes and treatment efficiency.

Drivers of this market include the increasing prevalence of cancer worldwide, prompting a demand for more targeted and effective therapies. Governments and healthcare institutions are investing heavily in precision medicine initiatives, recognizing their potential to revolutionize cancer treatment. The rise of patient-centric care models is also driving the adoption of precision oncology, as patients and healthcare providers seek tailored treatment options that improve quality of life and survival rates. With these trends and drivers, the Precision Oncology Technologies Market is poised for substantial growth, offering lucrative opportunities for stakeholders.

Restraints and Challenges:

The Precision Oncology Technologies Market is confronted with several significant restraints and challenges. Firstly, the high cost of precision oncology treatments and technologies restricts their accessibility, particularly in low-income regions. This financial barrier hinders widespread adoption and limits patient access to cutting-edge therapies. Secondly, the complexity and variability of cancer genomics present challenges in data interpretation and clinical decision-making. This complexity demands highly specialized expertise, which is not always readily available. Thirdly, regulatory hurdles and lengthy approval processes for new technologies can delay market entry and innovation. These regulatory challenges can stifle the pace of technological advancement. Fourthly, there is a lack of standardized protocols for precision oncology, leading to inconsistencies in treatment outcomes. This absence of standardization complicates the integration of precision oncology into routine clinical practice. Lastly, the need for robust data privacy and security measures is critical, as sensitive patient information is integral to precision oncology. Ensuring compliance with data protection regulations remains a formidable challenge.

Key Companies:

Guardant Health, Foundation Medicine, Caris Life Sciences, Tempus, Natera, Neo Genomics, Personalis, Adaptive Biotechnologies, Biodesix, Invitae, Onco Cyte, Freenome, Grail, Helix, Bristol Myers Squibb, Illumina, Strata Oncology, Genomic Health, Oncocyte Corporation, Epic Sciences

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Precision Oncology Technologies Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Precision Oncology Technologies Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Precision Oncology Technologies Market Outlook

  • 4.1 Precision Oncology Technologies Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Precision Oncology Technologies Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Precision Oncology Technologies Market Size

  • 6.1 Precision Oncology Technologies Market Size, by Value
  • 6.2 Precision Oncology Technologies Market Size, by Volume

7: Precision Oncology Technologies Market, by Type

  • 7.1 Market Overview
  • 7.2 Diagnostics
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Prognostics
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Predictive Biomarkers
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Others
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region

8: Precision Oncology Technologies Market, by Product

  • 8.1 Market Overview
  • 8.2 Genetic Tests
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Companion Diagnostics
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Liquid Biopsy
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Next-Generation Sequencing
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Immunohistochemistry
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Fluorescence In Situ Hybridization
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Others
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region

9: Precision Oncology Technologies Market, by Services

  • 9.1 Market Overview
  • 9.2 Consultation
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Genomic Profiling
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Data Interpretation
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Clinical Trial Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Precision Oncology Technologies Market, by Technology

  • 10.1 Market Overview
  • 10.2 Gene Sequencing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Polymerase Chain Reaction
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Microarray
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Bioinformatics
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Nanotechnology
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Precision Oncology Technologies Market, by Application

  • 11.1 Market Overview
  • 11.2 Breast Cancer
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Lung Cancer
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Colorectal Cancer
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Prostate Cancer
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Melanoma
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Leukemia
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Others
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region

12: Precision Oncology Technologies Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Diagnostic Laboratories
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Pharmaceutical Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Biotechnology Firms
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Precision Oncology Technologies Market, by Component

  • 13.1 Market Overview
  • 13.2 Software
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Hardware
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Reagents
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Kits
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Consumables
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Others
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region

14: Precision Oncology Technologies Market, by Deployment

  • 14.1 Market Overview
  • 14.2 On-Premises
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Cloud-Based
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Hybrid
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Precision Oncology Technologies Market, by Stage

  • 15.1 Market Overview
  • 15.2 Early-Stage Cancer
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Advanced-Stage Cancer
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Recurrent Cancer
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Precision Oncology Technologies Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Component
    • 16.2.9 North America Market Size and Forecast, by Deployment
    • 16.2.10 North America Market Size and Forecast, by Stage
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Component
      • 16.2.9.8 United States Market Size and Forecast, by Deployment
      • 16.2.9.9 United States Market Size and Forecast, by Stage
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Component
      • 16.2.10.8 Canada Market Size and Forecast, by Deployment
      • 16.2.10.9 Canada Market Size and Forecast, by Stage
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Component
    • 16.3.9 Europe Market Size and Forecast, by Deployment
    • 16.3.10 Europe Market Size and Forecast, by Stage
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Component
      • 16.3.10.8 Germany Market Size and Forecast, by Deployment
      • 16.3.10.9 Germany Market Size and Forecast, by Stage
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Component
      • 16.3.11.8 France Market Size and Forecast, by Deployment
      • 16.3.11.9 France Market Size and Forecast, by Stage
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Component
      • 16.3.12.8 Spain Market Size and Forecast, by Deployment
      • 16.3.12.9 Spain Market Size and Forecast, by Stage
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Component
      • 16.3.13.8 Italy Market Size and Forecast, by Deployment
      • 16.3.13.9 Italy Market Size and Forecast, by Stage
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Component
      • 16.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Component
      • 16.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 16.3.15.9 Sweden Market Size and Forecast, by Stage
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Component
      • 16.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Component
      • 16.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 16.3.17.9 Denmark Market Size and Forecast, by Stage
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Component
      • 16.3.18.8 Finland Market Size and Forecast, by Deployment
      • 16.3.18.9 Finland Market Size and Forecast, by Stage
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Component
      • 16.3.19.8 Russia Market Size and Forecast, by Deployment
      • 16.3.19.9 Russia Market Size and Forecast, by Stage
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Component
      • 16.4.9.8 China Market Size and Forecast, by Deployment
      • 16.4.9.9 China Market Size and Forecast, by Stage
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Component
      • 16.4.10.8 India Market Size and Forecast, by Deployment
      • 16.4.10.9 India Market Size and Forecast, by Stage
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Component
      • 16.4.11.8 Japan Market Size and Forecast, by Deployment
      • 16.4.11.9 Japan Market Size and Forecast, by Stage
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Component
      • 16.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 16.4.12.9 South Korea Market Size and Forecast, by Stage
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Component
      • 16.4.13.8 Australia Market Size and Forecast, by Deployment
      • 16.4.13.9 Australia Market Size and Forecast, by Stage
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Component
      • 16.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 16.4.14.9 Singapore Market Size and Forecast, by Stage
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Component
      • 16.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Component
      • 16.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Component
      • 16.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Component
    • 16.5.9 Latin America Market Size and Forecast, by Deployment
    • 16.5.10 Latin America Market Size and Forecast, by Stage
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Component
      • 16.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 16.5.9.9 Brazil Market Size and Forecast, by Stage
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Component
      • 16.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 16.5.10.9 Mexico Market Size and Forecast, by Stage
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Component
      • 16.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 16.5.11.9 Argentina Market Size and Forecast, by Stage
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Component
      • 16.6.10.8 UAE Market Size and Forecast, by Deployment
      • 16.6.10.9 UAE Market Size and Forecast, by Stage
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Component
      • 16.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 16.6.11.9 South Africa Market Size and Forecast, by Stage
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 AliveCor
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Withings
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Biobeat
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Qardio
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Empatica
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 iRhythm Technologies
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Garmin
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Omron Healthcare
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Fitbit
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Huami
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Polar Electro
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Bittium
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Hexoskin
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 VivaLNK
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 MyZone
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
  • 18.16 Sensoria
    • 18.16.1 Company Overview
    • 18.16.2 Company Snapshot
    • 18.16.3 Business Segments
    • 18.16.4 Business Performance
    • 18.16.5 Product Offerings
    • 18.16.6 Key Developmental Strategies
    • 18.16.7 SWOT Analysis
  • 18.17 CardiacSense
    • 18.17.1 Company Overview
    • 18.17.2 Company Snapshot
    • 18.17.3 Business Segments
    • 18.17.4 Business Performance
    • 18.17.5 Product Offerings
    • 18.17.6 Key Developmental Strategies
    • 18.17.7 SWOT Analysis
  • 18.18 Actxa
    • 18.18.1 Company Overview
    • 18.18.2 Company Snapshot
    • 18.18.3 Business Segments
    • 18.18.4 Business Performance
    • 18.18.5 Product Offerings
    • 18.18.6 Key Developmental Strategies
    • 18.18.7 SWOT Analysis
  • 18.19 Amazfit
    • 18.19.1 Company Overview
    • 18.19.2 Company Snapshot
    • 18.19.3 Business Segments
    • 18.19.4 Business Performance
    • 18.19.5 Product Offerings
    • 18.19.6 Key Developmental Strategies
    • 18.19.7 SWOT Analysis
  • 18.20 Wellue
    • 18.20.1 Company Overview
    • 18.20.2 Company Snapshot
    • 18.20.3 Business Segments
    • 18.20.4 Business Performance
    • 18.20.5 Product Offerings
    • 18.20.6 Key Developmental Strategies
    • 18.20.7 SWOT Analysis